Cardiac electrophysiology in diabetes

Minerva Cardioangiologica

Volumn 58, Issue 2, 2010, Pages 269-276

  Pappone, C ^a   Santlnelli, V ^a  

^a MARIA CECILIA HOSPITAL   (Italy)

Author keywords

Arrhythmias, cardiac; Death, sudden, cardiac; Diabetes mellitus

Indexed keywords

ATHEROSCLEROSIS; AUTONOMIC NEUROPATHY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE PREDISPOSITION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART MUSCLE ISCHEMIA; HEART REPOLARIZATION; HUMAN; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; QT PROLONGATION; REVIEW; SUDDEN DEATH; T WAVE;

ATRIAL FIBRILLATION; DEATH, SUDDEN, CARDIAC; DIABETES COMPLICATIONS; ELECTROPHYSIOLOGICAL PROCESSES; HEART; HUMANS; RISK;

EID: 77954714778     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Chen PS, Chou CC, Tan AY, Zhou S, Fishbein MC, Hwang C et al The mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol 2006;17(Suppl 3):S2-S7.
2. Khan R, Sheppard R. Fibrosis in heart disease: Understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology 2006;118:10-24.
3. Bakth S, Arena J, Lee W, Torres R, Haider B, Patel BC et al. Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning. J Clin Invest 1986;77:382-95. (Pubitemid 16037636)
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes; estimates for year 2000 and projections for 2030. Diabetes Care 2004;21:1047-53.
5. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005;105:315-8.
6. Ostgren CJ, Merlo J, Rastam L, Lindblad U. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab 2004;6:367-74.
7. Asia Pacific Cohort Studies Collaboration. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. The Asia Pacific Cohort Studies Collaboration. Diabetes Care 2003;26:360-6.
8. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73-8.
9. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995;98:476-84.
10. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-4.
11. Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007;115:3050-6.
12. Pappone C, Radinovic A, Manguso F, Vicedomini G, Ciconte G, Sacchi S et al. Atrial fibrillation progression and management: a 5-year prospective follow-up study. Heart Rhythm 2008;5:1501-7.
13. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22.
14. Friberg J, Scharling H, Gadsböll N, Truelsen T, Jensen GB, Copenhagen City Heart Study. Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol 2004,94:889-94.
15. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34.
16. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985;27:255-70.
17. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther 1994;8:65-73.
18. Zarich SW, Nesto RW. Diabetic cardiomyopathy. Am Heart J 1989;118:1000-12.
19. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007;115:3213-23.
20. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:2035-8.
21. Atrial fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
22. Illien S, Maroto-Jarvinen S, von der Recke G, Hammerstingl C, Schmidt H, Kuntz-Hehner S et al. Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism. Heart 2003;89:165-8. (Pubitemid 36115099)
23. Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2006;27:1979-2030.
24. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998;136:205-12.
25. Kannel WB, Wilson PW, D'Agostino RB, Cobb J. Sudden coronary death in women. Am Heart J 1998;136:205-12.
26. Curb JD, Rodriguez BL, Burchfiel CM, Abbott RD, Chiu D, Yano K. Related articles. Sudden death, impaired glucose tolerance, and diabetes in Japanese American men. Circulation 1995;91:2591-5.
27. Balkau B, Jouven X, Ducimetiere P, Eschwege E. Diabetes as a risk factor for sudden death. Lancet 1999;354:1968-9.
28. Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS. Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J 2005;26:2142-7.
29. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM et al. Association of hyperglycaemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000;86:309-12.
30. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM et al. Association of hyperglycaemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000;86:309-12.
31. Suarez GA, Clark VM, Norell JE, Kottke TE, Callahan MJ, O'Brien PC et al. Sudden cardiac death in diabetes mellitus: risk fadors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry 2005;76:240-5.
32. Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A et al.; ADVANCE Collaborative Group on behalf of the ADVANCE Collaborative GroupRisks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 2009;30:1128-35.
33. Patel A, ADVANCE Collaborative Group, MacMahon S et al. Effects of a fixed combination of Perindopril and Indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-40. (Pubitemid 47362321)
34. Miyaska Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP et al Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-25.
35. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J 1996;131:790-5.
36. Tsang TS, Petty GW, Barnes ME, O'Fallon WM, Bailey KR, Wiebers DO et al. The prevalence of atrial fibrillation in inddent stroke cases and matched population controls in Rochester, Minnesota: changes over three decades. J Am Coll Cardiol 2003;42:93-100.
37. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifitime risk for development of of atrial fibrillation: The Framingham Study. Circulation 2004;110:1042-6.
38. Nichols GA, Hillier TA, Brown JB. Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care 2007;30:228-33.
39. Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 2009;32:1851-6.
40. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB Sr et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009;373:739-45.